Metraipolis › archive › dc_cdce46e6c819

Control of SARS-CoV-2 infection after Spike DNA or Spike DNA+Protein co-immunization in rhesus macaques — Europe PMC PMID:34551020

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/34551020
DOI
10.1371/journal.ppat.1009701
License (as archived)
CC0-1.0
Archived
2026-11-02T16:51:19.318Z
SHA-256 of the archived text
10a1f3aee4c796a6bb53b808f1146a9983533af702fdb23fa731736cf9187927
Stable URL of this page
https://metraipolis.com/documento/dc_cdce46e6c819

How to cite

Control of SARS-CoV-2 infection after Spike DNA or Spike DNA+Protein co-immunization in rhesus macaques — Europe PMC PMID:34551020 — Europe PMC (en), https://europepmc.org/article/MED/34551020 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_cdce46e6c819 (Metraipolis archive dc_cdce46e6c819, sha256 10a1f3aee4c796a6bb53b808f1146a9983533af702fdb23fa731736cf9187927)
BibTeX
@misc{dccdce46e6c819,
  title = {Control of SARS-CoV-2 infection after Spike DNA or Spike DNA+Protein co-immunization in rhesus macaques — Europe PMC PMID:34551020},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/34551020},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_cdce46e6c819; sha256 10a1f3aee4c796a6bb53b808f1146a9983533af702fdb23fa731736cf9187927},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/34551020. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

The speed of development, versatility and efficacy of mRNA-based vaccines have been amply demonstrated in the case of SARS-CoV-2. DNA vaccines represent an important alternative since they induce both humoral and cellular immune responses in animal models and in human trials. We tested the immunogenicity and protective efficacy of DNA-based vaccine regimens expressing different prefusion-stabilized Wuhan-Hu-1 SARS-CoV-2 Spike antigens upon intramuscular injection followed by electroporation in rhesus macaques. Different Spike DNA vaccine regimens induced antibodies that potently neutralized SARS-CoV-2 in vitro and elicited robust T cell responses. The antibodies recognized and potently neutralized a panel of different Spike variants including Alpha, Delta, Epsilon, Eta and A.23.1, but to a lesser extent Beta and Gamma. The DNA-only vaccine regimens were compared to a regimen that included co-immunization of Spike DNA and protein in the same anatomical site, the latter of which showed significant higher antibody responses. All vaccine regimens led to control of SARS-CoV-2 intranasal/intratracheal challenge and absence of virus dissemination to the lower respiratory tract. Vaccine-induced binding and neutralizing antibody titers and antibody-dependent cellular phagocytosis inversely correlated with transient virus levels in the nasal mucosa. Importantly, the Spike DNA+Protein co-immunization regimen induced the highest binding and neutralizing antibodies and showed the strongest control against SARS-CoV-2 challenge in rhesus macaques.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PLoS pathogens, 2021 (prima pubblicazione 2021-09-22).
Identificativi: PMID 34551020 · PMCID PMC8489704 · DOI 10.1371/journal.ppat.1009701.
Descrittori MeSH principali: Macaca mulatta; Vaccines, DNA.
Pagina: https://europepmc.org/article/MED/34551020 — https://doi.org/10.1371/journal.ppat.1009701. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-02T16:43:08.830Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.